Ropeginterferon alfa‐2b in patients with genotype 1 chronic hepatitis C: Pharmacokinetics, safety, and preliminary efficacy

BACKGROUND AND AIM: Ropeginterferon alfa‐2b (P1101) is a novel long‐acting mono‐PEGylated recombinant proline interferon (IFN) conjugated to a 40 kDa branched polyethylene glycol (PEG) chain at its N‐terminus, allowing every‐two‐week injection. It received European Medicines Agency and Taiwan market...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Hsien‐Hong, Hsu, Shih‐Jer, Lu, Sheng‐Nan, Chuang, Wan‐Long, Hsu, Chao‐Wei, Chien, Rong‐Nan, Yang, Sien‐Sing, Su, Wei‐Wen, Wu, Jaw‐Ching, Lee, Tzong‐Hsi, Peng, Cheng‐Yuan, Tseng, Kuan‐Chiao, Qin, Albert, Huang, Yi‐Wen, Chen, Pei‐Jer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341194/
https://www.ncbi.nlm.nih.gov/pubmed/34386602
http://dx.doi.org/10.1002/jgh3.12613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341194/
https://www.ncbi.nlm.nih.gov/pubmed/34386602
http://dx.doi.org/10.1002/jgh3.12613

Ejemplares similares